Metabolite

KNApSAcK Entry

id C00018711
Name Cerulenin / Helicocerin / (+)-Cerulenin
CAS RN 17397-89-6
Standard InChI InChI=1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15)/b3-2+,6-5+/t10-,11-/m1/s1
Standard InChI (Main Layer) InChI=1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15)

Cluster

Phytochemical cluster
KCF-S cluster No. 8847

Link

ChEMBL

By standard InChI CHEMBL45627
By standard InChI Main Layer CHEMBL45627 CHEMBL2000322

KEGG

By LinkDB C12058

CTD

By CAS RN D002569

Species

Summary

Plant class

class name count

Family

family name count

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Cephalosporium caerulens 150420 Fungi

Human Protein / Gene in interaction

8 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
Q16637 Survival motor neuron protein Unclassified protein CHEMBL45627 CHEMBL1613842 (1)
4 / 2
P04062 Glucosylceramidase Enzyme CHEMBL45627 CHEMBL1613818 (1)
6 / 4
P10828 Thyroid hormone receptor beta NR1A2 CHEMBL45627 CHEMBL1614554 (1)
3 / 1
P49327 Fatty acid synthase Transferase CHEMBL45627 CHEMBL873666 (1) CHEMBL862461 (1)
CHEMBL960231 (1) CHEMBL985841 (1)
CHEMBL1839595 (1) CHEMBL2169042 (1)
0 / 0
P11473 Vitamin D3 receptor NR1I1 CHEMBL45627 CHEMBL1794311 (1)
2 / 3
P00352 Retinal dehydrogenase 1 Enzyme CHEMBL45627 CHEMBL1614458 (1)
0 / 0
P10636 Microtubule-associated protein tau Unclassified protein CHEMBL45627 CHEMBL1614250 (1) CHEMBL1614421 (1)
4 / 3
Q96KQ7 Histone-lysine N-methyltransferase EHMT2 Enzyme CHEMBL45627 CHEMBL1738442 (1)
0 / 0

CTD interaction (9)

compound gene gene name gene description interaction interaction type form reference
pmid
D002569 83939 EIF2A
EIF-2A
MST089
MSTP004
MSTP089
eukaryotic translation initiation factor 2A, 65kDa Cerulenin results in increased phosphorylation of EIF2A protein increases phosphorylation
protein 17283163
D002569 2081 ERN1
IRE1
IRE1P
IRE1a
hIRE1p
endoplasmic reticulum to nucleus signaling 1 (EC:2.7.11.1) Cerulenin affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA] affects reaction
/ affects splicing
protein 17283163
D002569 2194 FASN
FAS
OA-519
SDR27X1
fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) Cerulenin results in decreased activity of FASN protein decreases activity
protein 12798352
D002569 2194 FASN
FAS
OA-519
SDR27X1
fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) [Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine decreases abundance
/ decreases activity
protein 18723500
D002569 3172 HNF4A
HNF4
HNF4a7
HNF4a8
HNF4a9
HNF4alpha
MODY
MODY1
NR2A1
NR2A21
TCF
TCF14
hepatocyte nuclear factor 4, alpha Cerulenin inhibits the reaction [Fructose results in decreased expression of HNF4A mRNA] decreases expression
/ decreases reaction
mRNA 17992261
D002569 3172 HNF4A
HNF4
HNF4a7
HNF4a8
HNF4a9
HNF4alpha
MODY
MODY1
NR2A1
NR2A21
TCF
TCF14
hepatocyte nuclear factor 4, alpha Cerulenin inhibits the reaction [Glucose results in decreased expression of HNF4A mRNA] decreases expression
/ decreases reaction
mRNA 17992261
D002569 6462 SHBG
ABP
SBP
TEBG
sex hormone-binding globulin Cerulenin inhibits the reaction [Fructose results in decreased expression of SHBG protein] decreases expression
/ decreases reaction
protein 17992261
D002569 6462 SHBG
ABP
SBP
TEBG
sex hormone-binding globulin Cerulenin inhibits the reaction [Glucose results in decreased expression of SHBG protein] decreases expression
/ decreases reaction
protein 17992261
D002569 7494 XBP1
TREB5
XBP-1
XBP2
X-box binding protein 1 Cerulenin affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA] affects reaction
/ affects splicing
mRNA 17283163

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (19)

OMIM preferred title UniProt
#600274 Frontotemporal dementia; ftd P10636
#608013 Gaucher disease, perinatal lethal P04062
#230800 Gaucher disease, type i P04062
#230900 Gaucher disease, type ii P04062
#231000 Gaucher disease, type iii P04062
#231005 Gaucher disease, type iiic P04062
#607948 Mycobacterium tuberculosis, susceptibility to P11473
#168600 Parkinson disease, late-onset; pd P04062
#260540 Parkinson-dementia syndrome P10636
#172700 Pick disease of brain P10636
#253300 Spinal muscular atrophy, type i; sma1 Q16637
#253550 Spinal muscular atrophy, type ii; sma2 Q16637
#253400 Spinal muscular atrophy, type iii; sma3 Q16637
#271150 Spinal muscular atrophy, type iv; sma4 Q16637
#601104 Supranuclear palsy, progressive, 1; psnp1 P10636
#188570 Thyroid hormone resistance, generalized, autosomal dominant; grth P10828
#274300 Thyroid hormone resistance, generalized, autosomal recessive; grth P10828
#145650 Thyroid hormone resistance, selective pituitary; prth P10828
#277440 Vitamin d-dependent rickets, type 2a; vddr2a P11473

KEGG DISEASE (12)

KEGG disease name UniProt
H00066 Lewy body dementia (LBD) P04062 (related)
H00126 Gaucher disease P04062 (related)
H00426 Defects in the degradation of ganglioside P04062 (related)
H00810 Progressive myoclonic epilepsy (PME) P04062 (related)
H00058 Amyotrophic lateral sclerosis (ALS) P10636 (related)
H00077 Progressive supranuclear palsy (PSP) P10636 (related)
H00078 Frontotemporal lobar degeneration (FTLD) P10636 (related)
H00249 Thyroid hormone resistance syndrome P10828 (related)
H00342 Tuberculosis P11473 (related)
H00784 Localized autosomal recessive hypotrichosis P11473 (related)
H01143 Vitamin D-dependent rickets P11473 (related)
H00455 Spinal muscular atrophy (SMA) Q16637 (related)
Q16637 (related)

Diseases related to CTD interactions

2 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D008545 D002569 Melanoma therapeutic
20805790
D009369 D002569 Neoplasms therapeutic
20373869